|
We are building a portfolio of compounds that have first-in-class and best-in-class potential through our own discovery research and clinical development initiatives.
more >
|
 |
06/16/09
Exelixis Announces June 24 Webcast of Presentation at the Piper Jaffray Europe Conference
06/04/09
Exelixis Announces June 9 Webcast of Presentation at the Goldman Sachs Thirtieth Annual Healthcare Conference
|
|
Seven abstracts featuring Exelixis compounds will be presented at ASCO's annual meeting from May 29 to June 2, 2009.
more >
No events are scheduled at this time
|
|
Looking for a career at Exelixis? We are looking for people to join us as we turn our vision into reality.
more >
NASDAQ: EXEL
Jul 2 2009 4:00PM
PRICE: 4.72 -0.18
VOLUME: 676210 SHARES
20 minute delay
more >
|
